Genesys International Corporation Ltd (GENESYS) Financials - Quarterly Results, Profit & Loss, Balance Sheet, Cash Flow Genesys International Corporation Ltd reported sales of ₹81.36 Cr, operating profit of ₹28.13 Cr (OPM 34.57%) and net profit of ₹5.28 Cr for the quarter ended Jun 2026. Figures in ₹ crore, consolidated where available.
GENESYS quarterly results (₹ Cr) Metric Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sales 72.02 89.09 94.16 70.87 76.95 75.78 104.22 81.36 Expenses 42.64 46.52 44.39 41.37 46.96 60.03 70.12 53.23 Operating Profit 29.38 42.57 49.77 29.5 29.99 15.75 34.1 28.13 OPM 40.79% 47.78% 52.86% 41.63% 38.97% 20.78% 32.72% 34.57% Other Income 1 1.84 0.11 1.27 3.84 6.03 3.45 1.76 Interest 1.88 2.58 3.08 3.18 3.1 2.84 3.35 3.14 Depreciation 12.25 15.69 15.29 15.43 15.62 16.81 17.11 18.43 Profit before tax 16.25 26.14 31.51 12.16 15.11 2.13 17.09 8.32 Tax 31.69% 20.73% 39.73% 42.6% 20.25% 50.7% 25.57% 36.54% Net Profit 11.09 20.71 19 6.98 12.05 1.05 12.72 5.28 EPS in Rs 1.77 3.25 2.97 1.07 1.8 0.16 1.85 0.8
GENESYS profit & loss, annual (₹ Cr) Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM Sales 120 181 198 311 328 338 Expenses 92 122 117 168 218 230 Operating Profit 28 59 81 143 109 108 OPM 23% 32% 41% 46% 33% 32% Other Income -42 6 5 4 15 15 Interest 3 3 5 10 12 12 Depreciation 19 37 44 55 65 68 Profit before tax -36 25 37 83 46 43 Tax 11% 40% 42% 32% 29% - Net Profit -40 15 22 56 33 31 EPS in Rs 2.67 3.16 3.49 8.83 4.87 4.61 Dividend Payout 0% 0% 0% 0% 0% -
GENESYS balance sheet (₹ Cr) Metric Mar 2023 Mar 2024 Mar 2025 Sep 2025 Mar 2026 Equity Capital 19 20 20 21 21 Reserves 387 469 536 662 683 Borrowings 39 60 122 147 173 Other Liabilities 61 86 100 90 96 Total Liabilities 506 635 778 920 972 Fixed Assets 157 156 128 265 287 CWIP 65 113 156 4 1 Investments 51 0 0 0 0 Other Assets 232 366 495 652 684 Total Assets 506 635 778 920 972
GENESYS cash flows (₹ Cr) Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Cash from Operating Activity 28 -35 19 -53 16 Cash from Investing Activity -20 -188 -80 -18 -150 Cash from Financing Activity 12 215 71 50 139 Net Cash Flow 20 -9 11 -20 5 Free Cash Flow 6 -133 -64 -107 -43 CFO/OP 111% -49% 26% -29% 32%
GENESYS ratios Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Debtor Days 150 168 263 261 226 Cash Conversion Cycle 150 168 263 261 226 Working Capital Days 82 212 269 291 317 ROCE 4% 7% 8% 15% 8%